SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-17-256580
Filing Date
2017-08-14
Accepted
2017-08-14 06:08:35
Documents
3
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q AMENDMENT NO. 1 d406325d10qa.htm 10-Q/A 52135
2 EX-31.1 d406325dex311.htm EX-31.1 2360
3 EX-31.2 d406325dex312.htm EX-31.2 2339
  Complete submission text file 0001193125-17-256580.txt   57873
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-33415 | Film No.: 171026704
SIC: 2834 Pharmaceutical Preparations